Ethyl 2-[(3-fluorophenyl)amino]acetate, 98%, 100g

(2-Methylprop-1-en-1-yl)benzene, 95.0%, 1g

(R)-Morpholine-3,4-dicarboxylic acid 4-tert-butylester, 95.0%, 1g

1-Bromooctane>98.0%(GC)500mL

Methyl 2-amino-2-(3-bromo-4-chlorophenyl)acetate hydrochloride, 95.0%, 100mg

5-tert-Butyl 1-Pentafluorophenyl N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-glutamate>98.0%(HPLC)(N)1g

GC capillary column ROTI®Cap-1701 MS, 30 m, 0.25 mm, 0.50 µm, 1 Piece(s)

trans-2-Hexenyl acetate, 98.0%, 25g

2-Ethyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>95.0%(GC)(T)1g

8-Bromo-2-chloro-6-fluoroquinazoline, 95.0%, 2.5g

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-chloro-2-fluorophenyl)propanoic acid, 97%, 5g

Methyl 4-chloro-2-methylquinoline-8-carboxylate, 97%, 100mg

Ethyl 2-((2,4-difluorophenyl)amino)-2-oxoacetate, 95%, 5g